Z

ZS

Global management consulting for sales optimization

Business Technology Solutions Consultant Emerging Pharma

Full-TimePosted on 10/16/2026Deadline 10/16/27
No salary listed
Senior
Boston, MA, USA+1 moreMore locations: New York, NY, USA
HybridHybrid schedule combines work from home and on-site presence at client or ZS offices for most of the week. Travel to client and global offices as needed.
DevOps & InfrastructureCloud Engineering

About the job

Requirements
  • At least 5 years of consulting experience leading large-scale technology implementations.
  • Strong communication skills to convey technical concepts to diverse audiences.
  • Significant supervisory, coaching, and hands-on project management skills.
  • Extensive experience with major cloud platforms such as Amazon Web Services, Azure, and Google Cloud Platform.
  • Deep knowledge of enterprise data management, advanced analytics, process automation, and application development.
  • Familiarity with industry-standard products and platforms such as Snowflake, Databricks, Redshift, Salesforce, Power BI, and cloud technologies.
  • Experience delivering projects using agile methodologies.
  • Fluency in English.
  • Ability to manage a virtual global team to deliver multiple projects on time.
  • Experience analyzing and troubleshooting interactions between databases, operating systems, and applications.
  • Willingness to travel to global offices as required to collaborate with clients and internal project teams.
Responsibilities
  • Lead end-to-end projects using cloud technologies to solve complex business problems.
  • Provide technology expertise to maximize value for clients and project teams.
  • Drive delivery methodology to ensure projects are delivered on time, within budget, and to client satisfaction.
  • Ensure technology solutions are scalable, resilient, and optimized for performance and cost.
  • Guide, coach, and mentor project team members to support continuous learning and professional growth.
  • Demonstrate expertise and facilitate internal and client interactions.
  • Collaborate with ZS experts to drive innovation and minimize project risks.
  • Work with global team members to ensure smooth project delivery.
  • Structure unstructured work to develop business cases with clients.
  • Assist ZS leadership with business case development, innovation, thought leadership, and team initiatives.

About the company

ZS Associates helps organizations optimize their sales and marketing operations through data-driven analytics. The company uses mathematical models and rigorous analysis—originating from Kellogg professors in the 1980s—to size and structure sales teams, design territories, forecast markets, manage data, and design incentive compensation. Its services are delivered as consulting engagements that translate complex analytics into practical business decisions, such as how many salespeople a company needs, how to assign territories, and how to align incentives to drive performance. ZS differentiates itself with a deep, methodical focus on analytics, built from decades of experience and applied across industries beyond its pharmaceutical roots. The company’s goal is to help clients improve performance and return on investment by turning data into actionable sales and marketing solutions.

Company Size

10,001+

Company Stage

N/A

Total Funding

N/A

Headquarters

Evanston, Illinois

Founded

1983

Get referred to ZS

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • June 11, 2026 Toronto Engineering Labs adds $165 million and 300 jobs.
  • May 19, 2026 ZAIDYN launches cut insights 50-70% faster and content cycle times 67%.
  • June 2, 2026 Sapio partnership expands ZS into biopharma R&D and CMC digitization.

What critics are saying

  • MicroStrategy sued ZS in Virginia on September 11, 2025 for breach of contract.
  • Salesforce, Sapio, and ZS productize consulting work, compressing billable-hours growth by 2027.
  • If ZAIDYN execution stalls, life-sciences clients shift budget to native platforms and incumbents.

What makes ZS unique

  • ZS pairs 1983 sales-force analytics roots with regulated life-sciences implementation depth.
  • ZAIDYN now spans Medical and Content, embedding agentic AI into compliant workflows.
  • October 2025 Torrent Consulting acquisition strengthens Salesforce Life Sciences Cloud and Agentforce delivery.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Hybrid Work Options
  • Flexible Work Hours

Company News

PR Newswire
Oct 14th, 2026
ZS joins the Claude Partner Network as a Select partner to help enterprises put AI into production.

ZS joins the Claude Partner Network as a Select partner to help enterprises put AI into production. Oct 14, 2026, 09:00 ET ZS will help organizations scale AI across critical workflows in regulated industries EVANSTON, Ill., Oct. 14, 2026 /PRNewswire/ - ZS, a management consulting and technology firm, today announced that it has joined the Claude Partner Network as a Select partner in the Services Track to help organizations move AI from experimentation into scaled production. By bringing together the advanced AI capabilities of Claude, powered by Anthropic, with ZS's deep domain expertise and AI-driven implementation experience, the firm can accelerate adoption, improve productivity and deliver measurable business impact for clients in complex, regulated environments. The designation builds on successful deployments across software development, clinical research and pharmaceutical planning that are already driving gains in execution speed, productivity and AI adoption, including: * A recent Claude-powered workflow that cut the time required to generate key software-development artifacts by up to 83%. * A solution in clinical development for a global pharmaceutical company that drove 3x higher user adoption and improved feature-development efficiency by 30%-40%. "Enterprises are moving quickly from AI experimentation to scaled deployment, but powerful models alone aren't enough to create lasting value," said Swati Gokhale, ZS's principal and global leader of strategic alliances and investments. "It takes domain expertise, governance and execution to embed AI safely and responsibly into the decisions and workflows that shape business performance. By joining the Claude Partner Network, ZS is strengthening its ability to help clients do that." As a Select partner in the Services Track, ZS will help organizations: * Build industry-specific AI agents and applications for complex, highly regulated environments * Embed AI into business-critical decisions and workflows * Accelerate deployment through reusable implementation frameworks and governance standards * Scale successful pilots into enterprise-wide solutions This work draws on ZS's expertise in strategy, analytics, decision intelligence, technology and implementation, supported by thousands of AI experts and engineers across the firm. The designation extends ZS's alliance ecosystem - including Databricks, Veeva, Salesforce, AWS and Microsoft - and advantageously positions the firm to bring Claude into high-impact use cases spanning clinical development, commercial execution and enterprise operations. The Claude Partner Network "provides training, technical support, and joint market development for our partners helping enterprises adopt Claude," according to Anthropic. Learn more about the Claude Partner Network: https://www.anthropic.com/news/claude-partner-network About ZS ZS is a management consulting and technology firm that partners with companies to improve life and how we live it. We transform ideas into impact by bringing together data, science, technology and human ingenuity to deliver better outcomes for all. Founded in 1983, ZS has more than 15,000 employees in over 40 offices worldwide. To learn more, visit www.zs.com or follow us on LinkedIn.

PR Newswire
Sep 14th, 2026
ZS named a Leader in 2026 IDC MarketScape for Life Science R&D RWD and RWE.

ZS named a Leader in 2026 IDC MarketScape for Life Science R&D RWD and RWE. Sep 14, 2026, 17:24 ET Assessment recognizes ZS's capabilities across real-world data and evidence platforms, technology solutions and consulting services EVANSTON, Ill., Sept. 14, 2026 /PRNewswire/ - ZS, a global management consulting and technology firm, has been named a Leader in the IDC MarketScape: Worldwide Life Science R&D RWD/Real-World Evidence for Data Platforms, Technology Solutions, and Consulting Services 2026 Vendor Assessment (IDC # US54122226, [August] 2026). The IDC MarketScape evaluates organizations based on their capabilities and strategies related to real-world evidence (RWE), data, platforms, technologies and consulting services. This recognition follows ZS's recent recognition as a Leader in the IDC MarketScape: Worldwide Life Sciences R&D Strategic Consulting Services 2026 Vendor Assessment (May 2026, IDC #US53009826). "Life sciences organizations are looking for more connected approaches to evidence and decision-making across the product life cycle," said Rohan Fernando, managing principal of ZS's life sciences R&D and medical practice. "As the industry seeks to generate greater value from real-world data, organizations need better ways to turn evidence into action. Through integrated evidence planning and connected evidence-generation capabilities, we help clients transform RWD into decision-grade insights that inform regulatory, medical and business decisions. We're honored that IDC MarketScape recognized ZS as a Leader in the Life Sciences R&D RWD/RWE for Data Platforms, Technology Solutions, and Consulting Services 2026 Vendor Assessment." The IDC MarketScape notes several strengths of ZS, including the following: * ZS continues to scale its integrated Medical & Evidence practice that delivers connected medical, RWE, and HEOR strategies to accelerate decision-making. * [ZS] connects evidence generation to downstream dissemination, ensuring that the data that is generated supports publications, congress strategies, and field medical execution. * ZS offers ZAIDYN Medical (its medical intelligence platform), which features OLI for Opinion Leader Intelligence, CGI for Care Gap Intelligence, SMI for Scientific Medical Intelligence, MCE for Medical Customer Engagement for medical science liaisons (MSLs), and POI for Patient Outcomes Impact analysis. * ZS' AI-enabled Patient Radar platform identifies hard-to-find rare-disease patients and physicians. ZS reports that it helped accurately diagnose 26 new patients in 12 months for a rare disease organization. * In Europe, ZS Data Nexus is a proprietary, regulatory-grade RWD access platform, the first RWE solution to achieve Europrivacy certification. * ZS reports 90% NPS and 97% retention for its RWD/RWE work. * Its most differentiated asset is the digital Integrated Evidence Planning (IEP) capability, delivered through ZS Evidence Pro. With over 250 IEPs delivered, ZS reports that IEP development time was reduced from 4-5 months per IEP to generating over 30 IEPs in 10 weeks, with a 75% acceptance rate for over 20 protocol recommendations. As life sciences organizations face growing pressure to generate evidence that supports regulatory, medical and commercial decisions, the ability to connect strategy, data, technology and scientific expertise has become increasingly important. ZS remains focused on helping clients turn real-world data into decision-grade evidence and accelerate impact across the product life cycle. ZS is a management consulting and technology firm that partners with companies to improve life and how we live it. We transform ideas into impact by bringing together data, science, technology and human ingenuity to deliver better outcomes for all. Founded in 1983, ZS has more than 15,000 employees in over 40 offices worldwide. To learn more, visit www.zs.com or follow us on LinkedIn. About IDC MarketScape About IDC MarketScape: IDC MarketScape vendor assessment model is designed to provide an overview of the competitive fitness of technology and service suppliers in a given market. The research utilizes a rigorous scoring methodology based on both qualitative and quantitative criteria that results in a single graphical illustration of each supplier's position within a given market. IDC MarketScape provides a clear framework in which the product and service offerings, capabilities and strategies, and current and future market success factors of technology suppliers can be meaningfully compared. The framework also provides technology buyers with a 360-degree assessment of the strengths and weaknesses of current and prospective suppliers.

ARC Advisory Group
Jun 16th, 2026
Sapio Sciences and ZS partnership highlights formulation technology market momentum.

Sapio Sciences and ZS partnership highlights formulation technology market momentum. June 16, 2026 By Marianne D'Aquila Acquisition or Partnership Sapio Sciences announced a partnership with management consulting and technology firm ZS to support Sapio Platform deployments across biopharma research and development (R&D) and chemistry, manufacturing, and controls (CMC) laboratories. ZS has also joined the Sapio Partner Program as a consulting partner. The partnership brings together Sapio Platform capabilities with ZS consulting and implementation expertise. Together, the companies will offer services intended to support laboratory digitization, solution architecture, systems integration, change management, validation, and adoption for biopharma organizations. The collaboration is focused on enabling AI-ready, traceable laboratory data and governed workflows with human oversight. These capabilities are important for organizations operating in regulated R&D and CMC environments, where data integrity, scientific context, and compliance requirements are central to laboratory operations. Through the partnership, Sapio Platform customers can access ZS support across the deployment lifecycle, including: * Solution architecture. * System integration. * Change management and adoption. * Validation support. * Data integrity and compliance alignment. * Enterprise data and analytics integration. ZS brings consulting and implementation capabilities across several laboratory and life sciences areas. In R&D and discovery, the partnership is intended to help connect laboratory workflows with enterprise data environments and improve visibility into experiments, samples, and scientific results. In development and CMC, it supports the digitization of development and manufacturing laboratories, including integration with quality, regulatory, and enterprise data systems. The partnership also addresses laboratory informatics and data architecture by supporting scalable environments that connect Sapio Platform with enterprise data pipelines, analytics tools, and AI initiatives. This can help organizations redesign laboratory decision flows and improve cycle time across regulated scientific workflows. This collaboration between Sapio Sciences and ZS directly validates the framework established in ARC's upcoming Formulation Technologies MarketMap and Formulation Management Software MAR. Together, these research tools provide: * A transparent view of a complex supplier landscape. * A disciplined definition of formulation management software market boundaries and core domains. * Actionable insights into adoption patterns, capability trends, and the future of virtual-twin-driven R&D. Whether an organization is modernizing formulation workflows or a supplier is navigating a competitive market, this research offers a clear, forward-looking foundation. For more information about ARC MarketMap, visit: https://www.arcweb.com/arc-marketmap-technology-products-services.

Invest Ontario
Jun 11th, 2026
Invest Ontario welcomes ZS Engineering Labs.

Invest Ontario welcomes ZS Engineering Labs. Investment will create up to 300 high-skilled jobs and strengthen Ontario's AI, digital health, and life sciences ecosystem. TORONTO, Ontario, June 11, 2026 - Invest Ontario welcomes ZS's decision to expand its operations in the province through the creation of a new Engineering Labs in Toronto. The project represents a $165 million investment and is expected to create up to 300 high-skilled jobs over the next three to five years, supporting the company's long term growth in Ontario. ZS, a global management consulting and technology firm, is establishing the Engineering Labs to support its use of advanced technologies, including artificial intelligence, to deliver on its business strategies across healthcare, pharmaceutical and biotech clients. The investment reflects how AI is enabling companies to scale operations, drive innovation and expand high-value work. Invest Ontario worked with the firm to advance the project through strategic advisory services, including benchmarking analysis comparing operating costs across Ontario locations, helping build connections with local governments, universities, and ecosystem partners, and providing guidance on potential provincial and federal support programs to facilitate growth. ZS selected Ontario for its strong pipeline of highly skilled talent, as well as the strength of the province's AI, digital health, and life sciences ecosystem. A Toronto based operation provides access to North American clients and supports continued growth in a globally competitive market. By establishing its Engineering Labs in Toronto, ZS is expanding its AI-enabled capabilities and strengthening its presence in Ontario's innovation ecosystem. The project will contribute to the creation of high-value jobs and reinforce Ontario's position as a destination for advanced, knowledge-based investment. As global competition for technologies intensifies, companies are increasingly seeking stable, reliable and competitive conditions to develop and scale their products, ZS' decision to establish its new Engineering Labs in Toronto is a strong vote of confidence in Ontario's world-class STEM talent and AI ecosystem. We look forward to seeing their lab support the current and future needs of our life sciences and digital health sectors. Hon. Vic Fedeli Minister of Economic Development, Job Creation and Trade The ZS Engineering Labs in Toronto represents a strategic investment in AI talent and capabilities needed to help our clients innovate and transform at scale. Ontario offers a powerful combination of technical expertise, collaborative institutions, and a strong innovative ecosystem, making it an ideal location for advancing digital, Data and AI solutions across our client segments. Mahmood Majeed Principal, Head of Technology, ZS Ontario continues to demonstrate that it can deliver the talent, capability, and predictability companies need to grow. This investment strengthens our position in AI, digital health, and life sciences, and reflects our ability to compete for knowledge-based projects that translate into jobs, investment, and long-term economic growth for Ontario. At Invest Ontario, we work alongside companies as they grow, engage key stakeholders and connect with the ecosystem they need to scale successfully and build long-term operations in Ontario. Khawar Nasim CEO, Invest Ontario About Invest Ontario. Invest Ontario is the dedicated agency for investment attraction in the province. We serve as global businesses' partner and one-window access to Ontario, providing expertise and tailored services throughout their investment journey. With a focus on the advanced manufacturing, life sciences and technology sectors, we are committed to securing strategic investments that create jobs, generate returns to the province and drive Ontario's long-term economic growth and global competitiveness. About ZS. ZS is a management consulting and technology firm that partners with companies to improve life and how we live it. We transform ideas into impact by bringing together data, science, technology and human ingenuity to deliver better outcomes for all. Founded in 1983, ZS has more than 15,000 employees in over 40 offices worldwide. To learn more, visit www.zs.com or follow us on LinkedIn. Media contacts. Stephen Chiang Director, Communications, Invest Ontario INVEST ONTARIO. HERE TO HELP.

Business Wire
May 19th, 2026
ZS expands ZAIDYN AI platform with new Medical and Content suites for life sciences

ZS, a global management consulting and technology firm, has launched two new AI-powered application suites for the life sciences industry: ZAIDYN Medical and ZAIDYN Content. The platforms are part of ZS's expanded ZAIDYN intelligence platform, which uses agentic AI to address regulated, high-stakes workflows. ZAIDYN Medical helps medical affairs teams identify and engage key opinion leaders whilst generating insights 50-70% faster. The suite is backed by issued US patents and pending applications focused on AI-driven medical intelligence. ZAIDYN Content accelerates the life sciences content supply chain from creation through medical, legal and regulatory approval. Already deployed at enterprise scale, it has processed over 100,000 assets, reducing cycle time for personalised content by more than 67%. The platform embeds compliance and medical intelligence directly into review workflows.